Annual report pursuant to Section 13 and 15(d)

Revenue Sharing Agreements ("RSAs")

Revenue Sharing Agreements ("RSAs")
12 Months Ended
Nov. 30, 2019
Text Block [Abstract]  
Revenue Sharing Agreements ("RSAs")
. On February 9, 1999, the previous agreements with the Company’s Arizona Revenue Sharing investors were modified and replaced by a RSA for the state of Florida for a price of $1,000,000. The revenue sharing agreement applies to net storage revenues originating from specimens from within the state of Florida. The revenue sharing agreement entitles the investors to revenues of up to a maximum of 33,000 storage spaces.
. In 1996, the Company signed agreements with a group of investors entitling them to an
50% share of the Company’s 75% share of the annual storage fees (“net storage revenues”) less a deduction for 50% of billing and collection expenses generated by specimens stored in the Illinois Masonic Medical Center for a price of $1,000,000. The agreements were modified in 1998 to broaden the covered specimens to those originating in Illinois and its contiguous states and stored in Oldsmar, Florida for a maximum of up to 33,000 storage spaces.
. On May 31, 2001, the Company entered into an RSA with Red Rock Partners, an Arizona general partnership, entitling them to
shares in a portion of the Company’s net storage revenue generated by specimens originating from within the State of Texas for a price of $750,000. The investors are entitled to a 37.5% share of net storage revenues originating in the State of Texas to a maximum of 33,000 storage spaces. During fiscal 2008, Red Rock assigned 50% of their interest in the agreement to SCC Investments, Inc., an Arizona corporation. During fiscal year 2010, SCC Investments, Inc. assigned its interest to SCF Holdings, LLC, an Arizona limited liability company.
The Company made total payments to all RSA holders of $832,587 and $671,245 for the fiscal years ended November 30, 2019 and 2018, respectively. The Company recorded an RSA accrual of $909,765
and $798,292 as of November 30, 2019 and 2018,
respectively, related to interest owed to the RSA holders, which is included in accrued expenses. The Company also recorded interest expense
of $944,060 and $848,024
for the fiscal years ended November 30, 2019 and 2018, respectively, which is reflected in interest expense on the accompanying consolidated statements of comprehensive income (loss).